Hepatic Adenosine Triphosphate Reduction Through the Short‐Chain Fatty Acids–Peroxisome Proliferator‐Activated Receptor γ–Uncoupling Protein 2 Axis Alleviates Immune‐Mediated Acute Hepatitis in Inulin‐Supplemented Mice

How liver tolerance is disrupted in immune‐mediated liver injury is currently unclear. There is also insufficient information available regarding susceptibility, precipitation, escalation, and perpetuation of autoimmune hepatitis. To explore how dietary fiber influences hepatic damage, we applied th...

Full description

Bibliographic Details
Main Authors: Akihiro Yamaguchi, Toshiaki Teratani, Po‐sung Chu, Takahiro Suzuki, Nobuhito Taniki, Yohei Mikami, Shunsuke Shiba, Rei Morikawa, Takeru Amiya, Ryo Aoki, Takanori Kanai, Nobuhiro Nakamoto
Format: Article
Language:English
Published: Wiley 2021-09-01
Series:Hepatology Communications
Online Access:https://doi.org/10.1002/hep4.1742
id doaj-5cded46cbea3463ab293d9eb67a02cc8
record_format Article
collection DOAJ
language English
format Article
sources DOAJ
author Akihiro Yamaguchi
Toshiaki Teratani
Po‐sung Chu
Takahiro Suzuki
Nobuhito Taniki
Yohei Mikami
Shunsuke Shiba
Rei Morikawa
Takeru Amiya
Ryo Aoki
Takanori Kanai
Nobuhiro Nakamoto
spellingShingle Akihiro Yamaguchi
Toshiaki Teratani
Po‐sung Chu
Takahiro Suzuki
Nobuhito Taniki
Yohei Mikami
Shunsuke Shiba
Rei Morikawa
Takeru Amiya
Ryo Aoki
Takanori Kanai
Nobuhiro Nakamoto
Hepatic Adenosine Triphosphate Reduction Through the Short‐Chain Fatty Acids–Peroxisome Proliferator‐Activated Receptor γ–Uncoupling Protein 2 Axis Alleviates Immune‐Mediated Acute Hepatitis in Inulin‐Supplemented Mice
Hepatology Communications
author_facet Akihiro Yamaguchi
Toshiaki Teratani
Po‐sung Chu
Takahiro Suzuki
Nobuhito Taniki
Yohei Mikami
Shunsuke Shiba
Rei Morikawa
Takeru Amiya
Ryo Aoki
Takanori Kanai
Nobuhiro Nakamoto
author_sort Akihiro Yamaguchi
title Hepatic Adenosine Triphosphate Reduction Through the Short‐Chain Fatty Acids–Peroxisome Proliferator‐Activated Receptor γ–Uncoupling Protein 2 Axis Alleviates Immune‐Mediated Acute Hepatitis in Inulin‐Supplemented Mice
title_short Hepatic Adenosine Triphosphate Reduction Through the Short‐Chain Fatty Acids–Peroxisome Proliferator‐Activated Receptor γ–Uncoupling Protein 2 Axis Alleviates Immune‐Mediated Acute Hepatitis in Inulin‐Supplemented Mice
title_full Hepatic Adenosine Triphosphate Reduction Through the Short‐Chain Fatty Acids–Peroxisome Proliferator‐Activated Receptor γ–Uncoupling Protein 2 Axis Alleviates Immune‐Mediated Acute Hepatitis in Inulin‐Supplemented Mice
title_fullStr Hepatic Adenosine Triphosphate Reduction Through the Short‐Chain Fatty Acids–Peroxisome Proliferator‐Activated Receptor γ–Uncoupling Protein 2 Axis Alleviates Immune‐Mediated Acute Hepatitis in Inulin‐Supplemented Mice
title_full_unstemmed Hepatic Adenosine Triphosphate Reduction Through the Short‐Chain Fatty Acids–Peroxisome Proliferator‐Activated Receptor γ–Uncoupling Protein 2 Axis Alleviates Immune‐Mediated Acute Hepatitis in Inulin‐Supplemented Mice
title_sort hepatic adenosine triphosphate reduction through the short‐chain fatty acids–peroxisome proliferator‐activated receptor γ–uncoupling protein 2 axis alleviates immune‐mediated acute hepatitis in inulin‐supplemented mice
publisher Wiley
series Hepatology Communications
issn 2471-254X
publishDate 2021-09-01
description How liver tolerance is disrupted in immune‐mediated liver injury is currently unclear. There is also insufficient information available regarding susceptibility, precipitation, escalation, and perpetuation of autoimmune hepatitis. To explore how dietary fiber influences hepatic damage, we applied the concanavalin A (ConA)‐induced acute immune‐mediated liver injury model in mice fed a diet supplemented with 6.8% inulin, a water‐soluble fermentable fiber. Twelve hours after ConA administration, inulin‐supplemented diet‐fed mice demonstrated significantly alleviated hepatic damage histologically and serologically, with down‐regulation of hepatic interferon‐γ and tumor necrosis factor and reduced myeloperoxidase (MPO)‐producing neutrophil infiltration. Preconditioning with an inulin‐supplemented diet for 2 weeks significantly reduced hepatic adenosine triphosphate (ATP) content; suramin, a purinergic P2 receptor antagonist, abolished the protective effect. Of note, the portal plasma derived from mice fed the inulin‐supplemented diet significantly alleviated ConA‐induced immune‐mediated liver injury. Mechanistically, increased portal short‐chain fatty acid (SCFA) levels, such as those of acetate and butyrate, by inulin supplementation leads to up‐regulation of hepatic γ‐type peroxisome proliferator‐activated receptor (Pparg) and uncoupling protein 2 (Ucp2), which uncouples mitochondrial ATP synthesis downstream of PPARγ. Pparg down‐regulating small interfering RNA cancelled the protective effect of inulin supplementation against MPO‐producing neutrophil infiltration and the subsequent immune‐mediated liver injury, suggesting that the SCFA–PPARγ–UCP2 axis plays a key role in the protective effect by inulin supplementation. Moreover, significant changes in the gut microbiota, including increased operational taxonomic units in genera Akkermansia and Allobaculum, also characterized the protective effect of the inulin‐supplemented diet. Conclusion: There is a possible unraveled etiopathophysiological link between the maintenance of liver tolerance and dietary fiber. The SCFA–PPARγ–UCP2 axis may provide therapeutic targets for immune‐mediated liver injury in the future.
url https://doi.org/10.1002/hep4.1742
work_keys_str_mv AT akihiroyamaguchi hepaticadenosinetriphosphatereductionthroughtheshortchainfattyacidsperoxisomeproliferatoractivatedreceptorguncouplingprotein2axisalleviatesimmunemediatedacutehepatitisininulinsupplementedmice
AT toshiakiteratani hepaticadenosinetriphosphatereductionthroughtheshortchainfattyacidsperoxisomeproliferatoractivatedreceptorguncouplingprotein2axisalleviatesimmunemediatedacutehepatitisininulinsupplementedmice
AT posungchu hepaticadenosinetriphosphatereductionthroughtheshortchainfattyacidsperoxisomeproliferatoractivatedreceptorguncouplingprotein2axisalleviatesimmunemediatedacutehepatitisininulinsupplementedmice
AT takahirosuzuki hepaticadenosinetriphosphatereductionthroughtheshortchainfattyacidsperoxisomeproliferatoractivatedreceptorguncouplingprotein2axisalleviatesimmunemediatedacutehepatitisininulinsupplementedmice
AT nobuhitotaniki hepaticadenosinetriphosphatereductionthroughtheshortchainfattyacidsperoxisomeproliferatoractivatedreceptorguncouplingprotein2axisalleviatesimmunemediatedacutehepatitisininulinsupplementedmice
AT yoheimikami hepaticadenosinetriphosphatereductionthroughtheshortchainfattyacidsperoxisomeproliferatoractivatedreceptorguncouplingprotein2axisalleviatesimmunemediatedacutehepatitisininulinsupplementedmice
AT shunsukeshiba hepaticadenosinetriphosphatereductionthroughtheshortchainfattyacidsperoxisomeproliferatoractivatedreceptorguncouplingprotein2axisalleviatesimmunemediatedacutehepatitisininulinsupplementedmice
AT reimorikawa hepaticadenosinetriphosphatereductionthroughtheshortchainfattyacidsperoxisomeproliferatoractivatedreceptorguncouplingprotein2axisalleviatesimmunemediatedacutehepatitisininulinsupplementedmice
AT takeruamiya hepaticadenosinetriphosphatereductionthroughtheshortchainfattyacidsperoxisomeproliferatoractivatedreceptorguncouplingprotein2axisalleviatesimmunemediatedacutehepatitisininulinsupplementedmice
AT ryoaoki hepaticadenosinetriphosphatereductionthroughtheshortchainfattyacidsperoxisomeproliferatoractivatedreceptorguncouplingprotein2axisalleviatesimmunemediatedacutehepatitisininulinsupplementedmice
AT takanorikanai hepaticadenosinetriphosphatereductionthroughtheshortchainfattyacidsperoxisomeproliferatoractivatedreceptorguncouplingprotein2axisalleviatesimmunemediatedacutehepatitisininulinsupplementedmice
AT nobuhironakamoto hepaticadenosinetriphosphatereductionthroughtheshortchainfattyacidsperoxisomeproliferatoractivatedreceptorguncouplingprotein2axisalleviatesimmunemediatedacutehepatitisininulinsupplementedmice
_version_ 1717755137004404736
spelling doaj-5cded46cbea3463ab293d9eb67a02cc82021-09-12T17:38:40ZengWileyHepatology Communications2471-254X2021-09-01591555157010.1002/hep4.1742Hepatic Adenosine Triphosphate Reduction Through the Short‐Chain Fatty Acids–Peroxisome Proliferator‐Activated Receptor γ–Uncoupling Protein 2 Axis Alleviates Immune‐Mediated Acute Hepatitis in Inulin‐Supplemented MiceAkihiro Yamaguchi0Toshiaki Teratani1Po‐sung Chu2Takahiro Suzuki3Nobuhito Taniki4Yohei Mikami5Shunsuke Shiba6Rei Morikawa7Takeru Amiya8Ryo Aoki9Takanori Kanai10Nobuhiro Nakamoto11Division of Gastroenterology and Hepatology Department of Internal Medicine Keio University School of Medicine Tokyo JapanDivision of Gastroenterology and Hepatology Department of Internal Medicine Keio University School of Medicine Tokyo JapanDivision of Gastroenterology and Hepatology Department of Internal Medicine Keio University School of Medicine Tokyo JapanDivision of Gastroenterology and Hepatology Department of Internal Medicine Keio University School of Medicine Tokyo JapanDivision of Gastroenterology and Hepatology Department of Internal Medicine Keio University School of Medicine Tokyo JapanDivision of Gastroenterology and Hepatology Department of Internal Medicine Keio University School of Medicine Tokyo JapanDivision of Gastroenterology and Hepatology Department of Internal Medicine Keio University School of Medicine Tokyo JapanDivision of Gastroenterology and Hepatology Department of Internal Medicine Keio University School of Medicine Tokyo JapanDivision of Gastroenterology and Hepatology Department of Internal Medicine Keio University School of Medicine Tokyo JapanDivision of Gastroenterology and Hepatology Department of Internal Medicine Keio University School of Medicine Tokyo JapanDivision of Gastroenterology and Hepatology Department of Internal Medicine Keio University School of Medicine Tokyo JapanDivision of Gastroenterology and Hepatology Department of Internal Medicine Keio University School of Medicine Tokyo JapanHow liver tolerance is disrupted in immune‐mediated liver injury is currently unclear. There is also insufficient information available regarding susceptibility, precipitation, escalation, and perpetuation of autoimmune hepatitis. To explore how dietary fiber influences hepatic damage, we applied the concanavalin A (ConA)‐induced acute immune‐mediated liver injury model in mice fed a diet supplemented with 6.8% inulin, a water‐soluble fermentable fiber. Twelve hours after ConA administration, inulin‐supplemented diet‐fed mice demonstrated significantly alleviated hepatic damage histologically and serologically, with down‐regulation of hepatic interferon‐γ and tumor necrosis factor and reduced myeloperoxidase (MPO)‐producing neutrophil infiltration. Preconditioning with an inulin‐supplemented diet for 2 weeks significantly reduced hepatic adenosine triphosphate (ATP) content; suramin, a purinergic P2 receptor antagonist, abolished the protective effect. Of note, the portal plasma derived from mice fed the inulin‐supplemented diet significantly alleviated ConA‐induced immune‐mediated liver injury. Mechanistically, increased portal short‐chain fatty acid (SCFA) levels, such as those of acetate and butyrate, by inulin supplementation leads to up‐regulation of hepatic γ‐type peroxisome proliferator‐activated receptor (Pparg) and uncoupling protein 2 (Ucp2), which uncouples mitochondrial ATP synthesis downstream of PPARγ. Pparg down‐regulating small interfering RNA cancelled the protective effect of inulin supplementation against MPO‐producing neutrophil infiltration and the subsequent immune‐mediated liver injury, suggesting that the SCFA–PPARγ–UCP2 axis plays a key role in the protective effect by inulin supplementation. Moreover, significant changes in the gut microbiota, including increased operational taxonomic units in genera Akkermansia and Allobaculum, also characterized the protective effect of the inulin‐supplemented diet. Conclusion: There is a possible unraveled etiopathophysiological link between the maintenance of liver tolerance and dietary fiber. The SCFA–PPARγ–UCP2 axis may provide therapeutic targets for immune‐mediated liver injury in the future.https://doi.org/10.1002/hep4.1742